Escuche esta historia
--:--
1:57
Moderna reports the creation of vaccines for chickenpox, herpes and some types of cancer
The company is responsible for designing vaccines based on the same technology they used in the Covid-19 vaccine.
The company Moderna has reported that they are currently developing special vaccines to combat varicella-zoster (VZV) and herpes simplex (HSV).
In addition to these applications, they are responsible for creating special ones to combat two types of cancer. In this work they are based on messenger RNA technology, the same one used in the vaccine for Covid-19.
They have also recently announced that they have started the development of other vaccines for the Epstein-Barr virus (EBV), one against HIV and one to combat cytomegalovirus (CMV).
According to the published statement, they would be based on existing viruses that remain in the human body, after being infected.
Stéphane Bancel, the CEO of Moderna, notified that his commitment is to attack existing viruses with the aim of completely avoiding medical ailments with mRNA vaccine programs.
He added that soon they would be adding more lines to the five they currently have.
Until now, Moderna has only authorized the vaccine against Covid-19. In the process, they determined that the herpes simplex virus study serum targets the HSV-2 type. This is the culprit of infecting the genitals, to offer protection against the virus, which infects the genitals, mouth and face.
As for the herpes vaccine, the company designs a special process that expresses the E glycoprotein of the virus, so that the rate of herpes is significantly reduced, especially in the elderly population.
The adult population is the most susceptible to these lesions as it reactivates when its immunity declines.
For the vaccine that will manage to control cancer, they are responsible for achieving the stimulation of T-cells (lymphocytes, responsible for eliminating tumor cells). This vaccine will have two types of applications: non-small cell lung carcinoma and advanced or metastatic cutaneous melanoma.
